🔎 Trials Near Me

Home › Preeclampsia › Pennsylvania

Preeclampsia clinical trials in Pennsylvania

8 studies for Preeclampsia are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

Treatment With Aspirin After Preeclampsia: TAP Trial

  • University of Pittsburgh Magee-Womens Hospital, Pittsburgh
RecruitingPhase 4
Ages 18 to 55 · Women · Updated Sep 22, 2026 · NCT06281665

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

  • University of Pennsylvania, Philadelphia
RecruitingPhase 3
Ages 18 to 45 · Women · Updated Sep 10, 2026 · NCT06408181

Mobile Health Program for Post-Preeclampsia Hypertension

  • UPMC Magee Womens Hospital, Pittsburgh
Recruiting
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07599579

Non-Invasive Preeclampsia Screening and Biobank

  • Geisinger Medical Center, Danville
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · Women · Updated Jul 20, 2026 · NCT06643741

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

  • University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · Women · Updated May 22, 2026 · NCT07209254

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

  • University of Pittsburg Magee, Pittsburgh
RecruitingPhase 4
Ages 14 to 35 · Women · Updated May 4, 2026 · NCT06468202

Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories

  • University of Pittsburgh Magee-Womens Hospital, Pittsburgh
RecruitingPhase 2
Ages 18 and older · Women · Updated Apr 3, 2026 · NCT07041281

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

  • Thomas Jefferson University, Philadelphia
RecruitingPhase 1/2
Ages 16 to 55 · Women · Updated Jul 17, 2025 · NCT06826859

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.